Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan

Conclusion. VITROS Anti-SARS-CoV-2 total and IgG assays will be useful as supporting diagnostic and surveillance tools and for evaluation of humoral immune response to COVID-19. Optimal prediction of disease prognosis is made from considering both clinical history and laboratory findings.PMID:33861191 | DOI:10.1099/jmm.0.001291

Source: Journal of Medical Microbiology - April 16, 2021 Category: Microbiology Authors: Mayu Nagura-Ikeda Kazuo Imai Katsumi Kubota Sakiko Noguchi Yutaro Kitagawa Masaru Matsuoka Sakiko Tabata Kazuyasu Miyoshi Toshimitsu Ito Kaku Tamura Takuya Maeda Source Type: research